Fibro TG-HD-Gene Therapy Development and Validation for Huntington's Disease
Recruiting
This project aims to test a potential new treatment for Huntington’s disease called trans-splicing gene therapy. The goal is to see if this therapy can fix errors in the faulty Huntingtin gene, which causes the disease.
To do this, researchers will work with fibroblasts(skin cells) taken from people with HD done by a skin biopsy. These cells will be grown in the lab (in a dish) and used to study how well the therapy works.
Trans-splicing gene therapy works by replacing the faulty part of a gene’s message (called pre-messenger RNA) with a corrected version. The faulty message comes from inside the cell, and the corrected message is introduced from outside. This process could help the cell make a healthy version of the protein instead of a harmful one.
This an open label study with no phase assigned(not applicable). The intervention being the skin biopsy.
Ages Eligible
for Study:
18 Years to 70 Years
(Adult, Older Adult )
Sexes Eligible
for Study:
All
Accepts Healthy Volunteers:
No
- 18 ≤ age ≤ 70 years.
- Signed written, free and informed consent to participate in the study.
- Patients with a CAG≥36 allele (with reduced or full penetrance). penetrance)
- People affiliated to or benefiting from a social security scheme.
- Individuals who have participated in a gene therapy trial using AAV, ASO, mi/si/shRNA administration, likely to disrupt expression, splicing of pre-mRNAs, mRNA splicing, mRNA expression/regulation/translation, energy or protein metabolism directly or indirectly linked to the Huntingtin gene (HTT), its transcripts and proteins.
- Clinical or paraclinical elements that may suggest a differential diagnosis.
- People unable to express their consent.
- Pregnant, breast-feeding or parturient women
- People deprived of liberty by administrative or judicial decision
- People under legal protection (curatorship, guardianship).
LOCATION
FRANCE
TRIAL SITE:
Angers, Maine et Loire
Address: France
Contact: Charlotte ABRIAL, PhD
